In April 2026, a preprint appeared on bioRxiv with a title that got a lot of people’s attention: Metagenomics reveals a phylogenetically informed microbial signature associated with Morgellons disease. The authors, Andrea Nicole Lambert and William Kindschuh, ran deep metagenomic sequencing on lesion samples and unaffected skin from five members of a single family, all reporting Morgellons symptoms. It is, as far as I can tell, the first time anyone has pointed this particular tool — deep shotgun sequencing of everything genetic in a sample — at Morgellons lesions. In effect, it’s the first Morgellons metagenomic study of its kind.
That is genuinely worth paying attention to. It is also already being oversold. Within days of the preprint going up, posts were circulating declaring that “the DNA has spoken,” that the fibers are real, that this is “vindication,” that Morgellons has finally been “proven” to be a biological disease. I understand the pull of that. If you have spent years being told your symptoms are imaginary, a headline that says proof at last feels like oxygen. But a preprint like this one does not prove a microbial cause of Morgellons, identify a specific pathogen, or settle the larger debate over the disease, and reading it that way sets patients up for the next round of disappointment. The more useful thing — and the more durable thing — is to learn how to read a study like this honestly. So let’s do that.
What the Morgellons metagenomic study actually did
The researchers collected two types of material from each of five members of a single family: a postauricular skin swab — taken from the skin behind the ear — and a sample composed of pooled skin lesions collected at the same time. They then used deep, untargeted metagenomic sequencing to examine the non-human genetic material present in those samples.
The paired design has a real advantage. Because each person’s lesion sample is compared with a skin sample from the same individual, many person-to-person differences are reduced. Genetics, household exposures, diet, and other individual variables are less likely to explain a difference simply because one experimental group contains entirely different people.
But there is an important limitation here that is easy to miss. This was not a comparison between a Morgellons lesion and adjacent intact skin from the same anatomical location. The comparison samples came from the postauricular region, while the lesion samples consisted of pooled lesion material. Skin microbiomes vary by body site, and a swab of intact skin is not biologically or technically identical to material collected from multiple lesions. So the study is comparing more than simply “lesion” versus “not lesion.” Body site, tissue condition, and sample collection may all contribute to the signal.
That does not make the findings meaningless. It does mean the phrase “Morgellons microbial signature” should be handled carefully until the same pattern is reproduced using matched anatomical sites, independent patients, and appropriate wound controls.
With that design in mind, here’s what they report. The genetic material in the lesions included sequences that are poorly represented in existing reference databases — meaning the software couldn’t confidently match them to known organisms. They assembled draft genomes (called MAGs, or metagenome-assembled genomes) from the sequence data and found that the genomes built from lesions clustered differently, taxonomically, than the genomes built from the postauricular skin. Early descriptions of the preprint also report a broad taxonomic shift in the assembled genomes: postauricular samples leaned toward Bacillota and Actinomycetota, while lesion-associated MAGs leaned heavily toward Pseudomonadota — formerly called Proteobacteria — and Bacteroidota. On that basis the authors describe a “phylogenetically informed microbial signature” associated with the lesions, and they say — in their own careful words — that this motivates further investigation into a possible microbial etiology.
Notice the authors’ own framing. They do not say they found the cause of Morgellons. They say they found a signal worth chasing. That restraint is the most trustworthy thing in the paper, and it’s the part the hype coverage skips.
What it does not show — and why that matters
Here’s the media-literacy core, and it’s where patients are best served by slowing down.
A preprint is not peer-reviewed. bioRxiv is a place researchers post work before it has been vetted by independent reviewers. That’s not an insult; preprints are normal and useful. But it means no outside expert has yet checked the methods, the controls, or the statistics. Findings at this stage sometimes hold up and sometimes evaporate. Treating “posted on bioRxiv” as equivalent to “established fact” is exactly the kind of shortcut this site exists to push back on.
Five people from one family is a very small, very entangled sample. A single household shares far more than a diagnosis. They share bathrooms, bedding, pets, water, food, air, cleaning products, and a large fraction of their genes. If all five show a similar microbial pattern, that pattern could reflect their shared environment or shared genetics just as easily as it reflects Morgellons. There is no independent, unaffected control family here to compare against, so the study cannot separate “this is a Morgellons signature” from “this is a this-household signature.”
Layered on top of the body-site problem is a causation problem: a lesion is a biologically altered environment. This would apply even if the comparison had used perfectly matched anatomical sites. Once the skin barrier is disrupted, the local environment changes. Inflammation, moisture, tissue damage, oxygen conditions, and host defenses can all alter which microorganisms persist there. Studies comparing chronic wounds with intact skin have found markedly different bacterial communities.
So finding a microbial pattern in Morgellons lesions does not, by itself, establish that the microbes created the lesions. Several possibilities remain open. Microorganisms could help initiate the disease process. The lesion could create an ecological niche that selects for particular microbes. Secondary colonizers could accumulate after tissue damage has already occurred. Or host and microbial factors could reinforce each other.
The direction of causation is the whole question, and a snapshot comparison like this cannot answer it. The study design cannot separate those possibilities, and to their credit, the authors do not claim that it can.
“Sequences poorly represented in databases” does not mean “unknown pathogen.” Reference databases are famously incomplete, especially for skin and environmental organisms. Unmatched sequences turn up in metagenomic studies of perfectly ordinary samples all the time. It’s an interesting lead. It is not a discovery of alien biology, and it is not evidence of a bioengineered organism — a leap I’ve seen made elsewhere and one the data doesn’t support.
The preprint also describes a phylogenetic subtree composed exclusively of genomes assembled from lesion samples of the symptomatic individuals — the two subjects identified as having systemic symptoms in addition to cutaneous disease. That’s a genuinely interesting observation to file away. But with two individuals out of five, in one family, it is a hypothesis to test, not a mechanism that’s been shown. Reading it as evidence that a particular microbial cluster causes fatigue, cognitive dysfunction, or “brain fog” runs miles ahead of what two data points can carry.
Why overclaiming actually hurts patients
None of this is a reason to dismiss the study. It’s a reason to hold it correctly. And holding it correctly is not just intellectual hygiene — it protects patients.
When a modest, hedged preprint gets recast as “proof,” a few bad things follow. Patients invest hope in a result that may not replicate, and the eventual correction lands as another betrayal. Skeptical clinicians, who already lean toward the delusional-parasitosis label, get handed an easy reason to wave off the whole area: they see the “DNA has spoken” headlines, recognize the overreach, and quietly conclude the field isn’t serious. That’s the opposite of what patients need. The way this preprint earns real scientific traction is by being cited soberly, replicated in larger and unrelated cohorts, and built on — not by being turned into a meme.
It’s worth saying clearly what this study does helpfully do. It challenges the reflex that Morgellons is purely psychiatric and that there’s nothing biological to look at. What the Morgellons metagenomic study found is more specific than “there are bacteria in lesions.” The researchers assembled microbial genomes from the sequence data and identified a phylogenetically structured pattern associated with lesion samples. Researchers affiliated with Columbia University Irving Medical Center thought Morgellons warranted investigation with modern metagenomic tools. That is worth taking seriously. It is simply not the same thing as “case closed.”
What would actually move this forward
The authors themselves point the way, and it’s the right way: larger cohorts of unrelated patients; controls that are actually matched — the same anatomical site, plus wound controls of other causes to separate “Morgellons” from “chronic lesion”; layering in the host side of the picture, like immune profiling and proteomics; and independent replication by a second lab. If the signature is real and specific to Morgellons, it will survive that gauntlet. If it was a household artifact or ordinary lesion biology, it won’t. Either outcome is useful. That’s how the evidence gets stronger — or gets honestly corrected.
The bottom line
The Morgellons metagenomic study represents a real research effort to sequence these lesions deeply, and it found a microbial pattern in the lesions worth chasing. That’s good news, and it deserves to be reported as what it is: an early, small, not-yet-reviewed study that generates a hypothesis and calls for more work. The DNA didn’t “speak.” It cleared its throat. The responsible response — the one that actually serves patients — is to listen closely, ask for the follow-up studies, and resist anyone, on any side, who tells you a five-person preprint has settled a question this old.
Related reading on Morgellons Survey
- When It Might Not Be Morgellons: How to Rule Out Lookalikes Without Dismissing Patients
- Morgellons and Lyme Disease: Red Flags
- Morgellons research and resources
Sources
- Lambert AN, Kindschuh W. Metagenomics reveals a phylogenetically informed microbial signature associated with Morgellons disease. bioRxiv, posted April 16, 2026. doi:10.64898/2026.04.15.718803. Read the preprint.
- Gontcharova V, Youn E, Sun Y, Wolcott RD, Dowd SE. A Comparison of Bacterial Composition in Diabetic Ulcers and Contralateral Intact Skin. Open Microbiol J. 2010;4:8–19. Read the study.
